Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
clinical trials
6
×
life sciences
national blog main
boston blog main
boston top stories
drugs
national top stories
new york top stories
boston
fda
new york blog main
san francisco top stories
national
roche
san diego blog main
san diego top stories
san francisco blog main
accelerated approval
acute hepatic porphyria
aldehyde
aldeyra therapeutics
allergan
allergic conjunctivitis
allopregnanolone
alnylam pharmaceuticals
aminolevulinic acid
billy dunn
biogen
biotech
blueprint medicines
boulder/denver blog main
boulder/denver top stories
brexanolone
bristol-myers squibb
cancer
clinical data
companion diagnostic
detroit blog main
detroit top stories
dna sequencing
What
drug
6
×
medicine
6
×
new
6
×
approved
fda
data
oks
second
aldeyra
alnylam
atrophy
brexanolone
cancer
cleared
closer
daily
deeper
depression
devastating
disclosed
disease
disorder
dna
evrysdi
eye
far
fast
fatty
fighting
filing
fingerprint
friday
genetic
going
green
home
horizon
inflammation
intended
intercept
Language
unset
Current search:
medicine
×
drug
×
" clinical trials "
×
new
×
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
5 years ago
New Data Puts Aldeyra One Step Closer to FDA Filing for Eye Drug
@xconomy.com
5 years ago
FDA OKs Depression Drug For New Moms: Fast Relief But Tough to Take
@xconomy.com
5 years ago
With New Data, Intercept On Track for First-Ever Approved NASH Drug
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
@xconomy.com
5 years ago
With New Data, Alnylam Could Seek Speedy OK For Second RNAi Drug